SSR 504734
Alternative Names: SSR-504734Latest Information Update: 17 Mar 2009
At a glance
- Originator sanofi-aventis
- Class Antipsychotics
- Mechanism of Action Glycine transporter 1 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Schizophrenia